Stem cell treatment for MS is a promising new approach to addressing the disease’s progression and its associated symptoms. Our stem cell therapy for MS addresses its progressive and incapacitating symptoms while also targeting nerve cell repair by utilizing the powerful healing mechanisms of mesenchymal stem cells derived from Wharton’s jelly.
Multiple Sclerosis is a serious condition that attacks the nervous system directly and gradually incapacitates the brain, spinal cord, and optic nerves. In severe cases, the patient may become paralyzed, blind, and experience a variety of unpredictable symptoms throughout their body.
Stem cell therapy for multiple sclerosis is a promising new approach to addressing the disease’s progression and its associated symptoms. Our stem cell treatment for MS addresses the progressive and incapacitating symptoms while also targeting nerve cell repair. It does this by utilizing the powerful healing mechanisms of mesenchymal stem cells derived from Wharton’s jelly.
Our stem cell treatment for MS uses the healing properties of mesenchymal stem cells (MSCs). Not only do MSCs stimulate nerve tissue repair, they also reduce inflammation and prevent further nerve cell death. MSCs can also detect changes in the body that cause pain or dysfunction. Once damage is detected, these healing cells – which act as central nervous system protectors – migrate to damaged myelin zones of brain tissue to repair them. However, MSCs are distributed throughout the body, and the concentration of MSCs in an affected area is usually insufficient to fight or alleviate a progressive disease like MS.
Stemwell’s stem cell treatments for MS can immediately address its debilitating symptoms, while at the same time instigating a long-term strategy of healing and repair. The action of implanting Wharton’s jelly-derived stem cells into the affected area effectively floods it with pure MSCs, also known as “repair cells”. They:
Stemwell’s proprietary delivery protocols are specifically designed to open up the blood-brain barrier (BBB) to ensure that the processed stem cells travel directly into the brain. This enables correct blood flow to be re-established, damaged nerve cells (or neurons) to be repaired and, most importantly, myelin sheathings to be restored. Overall, all this process plays a major part in halting MS’s future progression of symptoms.
Stemwell uses cord tissue-derived mesenchymal stem cells ethically sourced from full-term human umbilical cords. We administer more than 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, it is extremely safe and does not require HLA or phenotypic matching.
Video call with one of our doctors, where patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor. The patient is later sent to rest at their hotel.
Application of 3 Million x Kg of weight distributed in 2 intrathecal applications, under sedation in the surgery room and two endogenous applications.
Oral Detox in children.
5 sessions – Hyberbaric chamber
(xxmin per session)
5 sessions – Transcranial Magnetotherapy
(45min per session)
5 sessions Biophotomodulation
(30min per session)
We all take simple daily tasks for granted, such as getting out of bed in the morning, walking, or even talking to our loved ones. All of these seemingly simple functions, however, are completely dependent on a functioning central nervous system, brain and spinal cord.
As an example, when a healthy person decides to get out of bed, their brain makes the decision to stand up. Nerve cells communicate with one another via pathways that connect them throughout the nervous system; they are then protected by myelin sheathings. The brain sends signals along this nervous network, through the spinal cord, and to the person’s extremities, causing him or her to stand up and out of bed.
However, in a person with MS, the myelin sheathings are mistakenly attacked by the person’s own immune system, destroying this protective cover and, as a result, the underlying nerve fiber is inevitably damaged. It is then impossible for nerve cells to transmit signals and perform their functions, so the person gradually loses control of their own body. As the disease progresses, ongoing inflammation and nerve tissue damage result in temporary and permanent symptoms such as numbness, paralysis, and blindness.
Stemwell collects the stem cells for MS treatment from human umbilical cord tissue. They and are used to treat autoimmune diseases (allogeneic mesenchymal). These stem cells are expanded in our cutting-edge laboratory.
The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother’s medical history is checked, and she is tested for infectious diseases. Prior to donation, each family provides written consent.
Before being approved for use in patients, all umbilical cord-derived stem cells are tested for infectious diseases in accordance with International Blood Bank Standards.
Only a small percentage of donated umbilical cords make it through our stringent screening process.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
AddressCra. 13 #118-08, Bogotá, Colombia
Free Toll Phone: +1 (833) 783-6935
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.